Health Care Professional Information

Downloadable resources

Download Pharmacy Fact Sheet (168 kb)
Download GP Fact Sheet (675 kb)

Clinical Research

1. Griffiths K, et al. Phytoestrogens and diseases of the prostate gland. Bailliere's Clinical Endocrinology and Metabolism. 1998; 12(4); 625-647.
2. Katz A. Flavonoid and Botanical approaches to Prostate Health, Review. Journal of Alternative and Complementary Medicine. 2003; 8(6); 813-823.
3. Kimira M et al. Japanese Intake of Flavonoids and Isoflavonoids from Foods. Journal of Epidemiology. 1998; 8(3); 168-175.
4. Adlercreutz H et al. Plasma concentrations of phyto-oestrogens in Japanese Men. The Lancet. 1993; 342; 1209-1210.
5. Ekman P. BPH epidemiology and risk factors. Prostate Supplement. 1989; 2; 23-31.
6. Evans et al. Inhibition of 5α-reductase in Genital Skin Fibroblasts and Prostate Tissue by Dietary Lignans and Isoflavonoids. Journal of Endocrinology (1995) 147, 295-302.
7. Campbell DR, and Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Molec Biol 1993; 46(3):381-388.
8. Lund TD, Munson DJ, Haldy ME, Setchell KDR, Lephart ED, and Handa RJ. Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback. Biology of Reproduction 2004; 70:1188-1195.
9. Gerber G, et al. The Use of Standardized Extract of Red Clover Isoflavones for the Alleviation of BPH Symptoms. Presented at 82nd Annual Meeting of the Endocrine Society, Canada June 2000.
10. Gaynor, M. Isoflavones and the prevention and treatment of prostate disease: Is there a role?
11. Cleveland Clinic Journal of Medicine 2003 Vol 70 (3), 203-216.
12. Jarred R et al. Induction of Apoptosis in Low to Moderate-Grade Human Prostate Carcinoma by Red Clover-derived Dietary Isoflavones. Cancer Epidemiology, Biomarkers and Prevention 2002 Vol 11, 1689-1696.

Further Information

If you require further information please complete the enquiry form below.